SAN JOSE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the UBS Global Life Sciences Conference, to be held September 22-25, 2008, at the Grand Hyatt Hotel in New York City.

VNUS' presentation is currently scheduled for 11:30 a.m. ET on Thursday, September 25, and will be webcast on the corporate website at http://ir.vnus.com/events.cfm. The management speaker will be Brian Farley, President and Chief Executive Officer. An archive of the webcast will be available through October 25, 2008.

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com .

SOURCE VNUS Medical Technologies, Inc.